Global Clinical Trials Software Market 2023
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The clinical trials software market is projected to grow at a CAGR of 11.5% from 2023 to 2029, reaching a value of $2.33 billion by 2029, up from $1.05 billion in 2022. Clinical trials play a vital role in disease treatment and improving detection, diagnosis, and prevention. The markets growth is driven by pharmaceutical organizations cost reduction demands and technology advancements. Clinical trial software (CTMS) helps manage research activities for contract research organizations (CROs). The global increase in clinical trials necessitates software solutions for easy access to activities. The biopharmaceutical industry has seen changes, with CROs becoming integral to clinical trial services. CTMS streamlines the process. The COVID-19 pandemic accelerated the digitization of trials, leading to increased adoption of digital tools and remote monitoring devices. Cloud computing offers opportunities for market vendors. Virtual trials gain traction with software enabling increased patient enrollment. Virtual patient recruitment software eliminates travel, automates data collection, and enhances engagement. Key players prefer unified platforms. Medidata offers a comprehensive unified platform. IQVIA is a leading pharmaceutical company in cloud computing. Digital tools address cost and timeline challenges. The pandemic prompted software use for vaccine production and trials.
The report covers market size and growth, segmentation, competitive landscape, trends and strategies for global clinical trials software market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
Market Segmentation
The market is segmented based on various factors, including deployment, delivery, feature, end-user, and geography.
Deployment: on-enterprises, on-site
Delivery: web-based, SaaS, on-premises
Feature: EDC, eCOA/ePRO, eConsent
End user: CROs, bio-pharmaceutical companies, medical device manufacturers, others
Segmentation by Geography
North America US, Canada
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan, India, South Korea, Australia
Latin America Brazil, Mexico, Argentina
Middle East & Africa South Africa, Saudi Arabia, Turkey, UAE
The clinical trial software market is divided into on-enterprises and on-site segments. In 2022, on-enterprises held the dominant position, accounting for 78.6% of the market. This is due to the increasing adoption of technology in biopharmaceutical companies and the usage of clinical trial management systems. On-site deployment offers advantages to contracting research organizations, sponsors, and academic and government institutes. Biopharmaceutical companies with their own IT infrastructure find it easier to handle CTMS solutions, reducing costs and timelines.
Web-based delivery was the dominant segment in 2022, accounting for 44.5% of the market share. Major biopharmaceuticals prefer web-based delivery for seamless data management, analysis, medical writing, and regulatory submission. It enables quick reviews and efficient data collection from participants through internet platforms, reducing errors and confusion. The increasing competitiveness in the biopharma and contract research industries drives the demand for software. Web-based delivery provides faster delivery and is associated with the acceptance of Software-as-a-Service (SaaS) in CTMS.
The global clinical trials software market is further segmented into EDC, eCOA/ePRO, and eConsent. EDC, also known as eCRF, is vital for collecting and analyzing patient data. The increasing demand for participant data and the use of EDC contribute to significant market growth, with a share of 46.6% in 2022.
CROs accounted for 45.7% of the market share in 2022. They experience high demand for medical research from biopharmaceutical companies, medical device manufacturers, and other authorities. Intense competition, high investments, and low success rates of clinical trials drive the demand for CROs.
North America has the largest market share, with 34.3% in 2022. This is due to the presence of key market players, a high number of biopharmaceutical companies, and significant research and development expenditure in the region.
Competitive Landscape
The global clinical trial software market is highly competitive due to collaboration, cloud-based platforms, and new solutions. Regional companies in Europe, APAC, and North America are investing in advanced software products, posing a threat to global players. This creates growth opportunities for existing and emerging players. Key companies profiled include Advarra, Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario, Inc., ClinCapture , Inc., Dassault Systemes SE, Datatrak International, Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare, Inc., Fortress Medical Systems, LLC, IBM Corporation, IQVIA Holdings, Inc., Labcorp Drug Development Inc., Medrio, Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health, Inc., Veeva Systems Inc., among others.
Scope of the Report
To analyze and forecast the market size of the global clinical trials software market.
To classify and forecast the global clinical trials software market based on deployment, delivery, feature, end user, geography.
To identify drivers and challenges for the global clinical trials software market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trials software market.
To identify and analyze the profile of leading players operating in the global clinical trials software market.
Why Choose This Report
Gain a reliable outlook of the global clinical trials software market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Companies Mentioned
Advarra Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario Inc., ClinCapture Inc., Dassault Systemes SE, Datatrak International Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare Inc., Fortress Medical Systems LLC, IBM Corporation, IQVIA Holdings Inc., Labcorp Drug Development Inc., Medrio Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health Inc., Veeva Systems Inc.
The report covers market size and growth, segmentation, competitive landscape, trends and strategies for global clinical trials software market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
Market Segmentation
The market is segmented based on various factors, including deployment, delivery, feature, end-user, and geography.
Deployment: on-enterprises, on-site
Delivery: web-based, SaaS, on-premises
Feature: EDC, eCOA/ePRO, eConsent
End user: CROs, bio-pharmaceutical companies, medical device manufacturers, others
Segmentation by Geography
North America US, Canada
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan, India, South Korea, Australia
Latin America Brazil, Mexico, Argentina
Middle East & Africa South Africa, Saudi Arabia, Turkey, UAE
The clinical trial software market is divided into on-enterprises and on-site segments. In 2022, on-enterprises held the dominant position, accounting for 78.6% of the market. This is due to the increasing adoption of technology in biopharmaceutical companies and the usage of clinical trial management systems. On-site deployment offers advantages to contracting research organizations, sponsors, and academic and government institutes. Biopharmaceutical companies with their own IT infrastructure find it easier to handle CTMS solutions, reducing costs and timelines.
Web-based delivery was the dominant segment in 2022, accounting for 44.5% of the market share. Major biopharmaceuticals prefer web-based delivery for seamless data management, analysis, medical writing, and regulatory submission. It enables quick reviews and efficient data collection from participants through internet platforms, reducing errors and confusion. The increasing competitiveness in the biopharma and contract research industries drives the demand for software. Web-based delivery provides faster delivery and is associated with the acceptance of Software-as-a-Service (SaaS) in CTMS.
The global clinical trials software market is further segmented into EDC, eCOA/ePRO, and eConsent. EDC, also known as eCRF, is vital for collecting and analyzing patient data. The increasing demand for participant data and the use of EDC contribute to significant market growth, with a share of 46.6% in 2022.
CROs accounted for 45.7% of the market share in 2022. They experience high demand for medical research from biopharmaceutical companies, medical device manufacturers, and other authorities. Intense competition, high investments, and low success rates of clinical trials drive the demand for CROs.
North America has the largest market share, with 34.3% in 2022. This is due to the presence of key market players, a high number of biopharmaceutical companies, and significant research and development expenditure in the region.
Competitive Landscape
The global clinical trial software market is highly competitive due to collaboration, cloud-based platforms, and new solutions. Regional companies in Europe, APAC, and North America are investing in advanced software products, posing a threat to global players. This creates growth opportunities for existing and emerging players. Key companies profiled include Advarra, Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario, Inc., ClinCapture , Inc., Dassault Systemes SE, Datatrak International, Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare, Inc., Fortress Medical Systems, LLC, IBM Corporation, IQVIA Holdings, Inc., Labcorp Drug Development Inc., Medrio, Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health, Inc., Veeva Systems Inc., among others.
Scope of the Report
To analyze and forecast the market size of the global clinical trials software market.
To classify and forecast the global clinical trials software market based on deployment, delivery, feature, end user, geography.
To identify drivers and challenges for the global clinical trials software market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global clinical trials software market.
To identify and analyze the profile of leading players operating in the global clinical trials software market.
Why Choose This Report
Gain a reliable outlook of the global clinical trials software market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Companies Mentioned
Advarra Inc., ArisGlobal LLC, Axiom Real-Time Metrics Inc., BSI Business Systems Integration AG, Ciwit B.V. (Castor), Clario Inc., ClinCapture Inc., Dassault Systemes SE, Datatrak International Inc. (Fountayn LLC), Datatrial Limited, Dotmatics Limited (Statsols), Florence Healthcare Inc., Fortress Medical Systems LLC, IBM Corporation, IQVIA Holdings Inc., Labcorp Drug Development Inc., Medrio Inc., Oracle Corporation, PAREXEL International Corporation, Reify Health Inc., Veeva Systems Inc.
TABLE OF CONTENTS
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DEPLOYMENT
5.1 On-enterprises
5.2 On-site
PART 6. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DELIVERY
6.1 Web-based
6.2 SaaS
6.3 On-premises
PART 7. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY FEATURE
7.1 EDC
7.2 ECOA/ePRO
7.3 EConsent
PART 8. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY END USER
8.1 CROs
8.2 Bio-pharmaceutical companies
8.3 Medical device manufacturers
8.4 Others
PART 9. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY GEOGRAPHY
9.1 North America
9.2 Europe
9.3 APAC
9.4 Latin America
9.5 Middle East & Africa
PART 10. COMPANY PROFILES
10.1 Advarra, Inc.
10.2 ArisGlobal LLC
10.3 Axiom Real-Time Metrics Inc.
10.4 BSI Business Systems Integration AG
10.5 Ciwit B.V. (Castor)
10.6 Clario, Inc.
10.7 ClinCapture , Inc.
10.8 Dassault Systemes SE
10.9 Datatrak International, Inc. (Fountayn LLC)
10.10 Datatrial Limited
10.11 Dotmatics Limited (Statsols)
10.12 Florence Healthcare, Inc.
10.13 Fortress Medical Systems, LLC
10.14 IBM Corporation
10.15 IQVIA Holdings, Inc.
10.16 Labcorp Drug Development Inc.
10.17 Medrio, Inc.
10.18 Oracle Corporation
10.19 PAREXEL International Corporation
10.20 Reify Health, Inc.
10.21 Veeva Systems Inc.
DISCLAIMER
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DEPLOYMENT
5.1 On-enterprises
5.2 On-site
PART 6. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY DELIVERY
6.1 Web-based
6.2 SaaS
6.3 On-premises
PART 7. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY FEATURE
7.1 EDC
7.2 ECOA/ePRO
7.3 EConsent
PART 8. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY END USER
8.1 CROs
8.2 Bio-pharmaceutical companies
8.3 Medical device manufacturers
8.4 Others
PART 9. GLOBAL CLINICAL TRIALS SOFTWARE MARKET BY GEOGRAPHY
9.1 North America
9.2 Europe
9.3 APAC
9.4 Latin America
9.5 Middle East & Africa
PART 10. COMPANY PROFILES
10.1 Advarra, Inc.
10.2 ArisGlobal LLC
10.3 Axiom Real-Time Metrics Inc.
10.4 BSI Business Systems Integration AG
10.5 Ciwit B.V. (Castor)
10.6 Clario, Inc.
10.7 ClinCapture , Inc.
10.8 Dassault Systemes SE
10.9 Datatrak International, Inc. (Fountayn LLC)
10.10 Datatrial Limited
10.11 Dotmatics Limited (Statsols)
10.12 Florence Healthcare, Inc.
10.13 Fortress Medical Systems, LLC
10.14 IBM Corporation
10.15 IQVIA Holdings, Inc.
10.16 Labcorp Drug Development Inc.
10.17 Medrio, Inc.
10.18 Oracle Corporation
10.19 PAREXEL International Corporation
10.20 Reify Health, Inc.
10.21 Veeva Systems Inc.
DISCLAIMER
RELATED REPORTS
Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View Report2024 Global Clinical Chemistry Immunodiagnostics Market
2024 Global Clinical Chemistry and Immunodiagnostics Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 100 Tests, Emerging Technologies and Trends, Instrumentation Pipeline, Growth OpportunitiesThe new
View ReportGlobal Clinical Chemistry Immunodiagnostics Market Supplier Shares
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan--2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
